Author
Listed:
- Morgane Guillou-Landreat
(INSERM UMR 1246, SPHERE, Methods in Patient-Centered Outcomes and Health Research, Nantes and Tours Universities, 44000 Nantes, France
EA 7479 SPURBO, Universite Bretagne Occidentale, 29200 Brest, France
HUGOPSY Network, 35000 Rennes, France)
- Antoine Dany
(EA 7479 SPURBO, Universite Bretagne Occidentale, 29200 Brest, France)
- Gaëlle Challet-Bouju
(INSERM UMR 1246, SPHERE, Methods in Patient-Centered Outcomes and Health Research, Nantes and Tours Universities, 44000 Nantes, France
CHU Nantes, Addictology and Psychiatry Department, Nantes University Hospital, 44000 Nantes, France)
- Edouard Laforgue
(INSERM UMR 1246, SPHERE, Methods in Patient-Centered Outcomes and Health Research, Nantes and Tours Universities, 44000 Nantes, France
CHU Nantes, Addictology and Psychiatry Department, Nantes University Hospital, 44000 Nantes, France)
- Juliette Leboucher
(CHU Nantes, Addictology and Psychiatry Department, Nantes University Hospital, 44000 Nantes, France)
- Jean Benoit Hardouin
(INSERM UMR 1246, SPHERE, Methods in Patient-Centered Outcomes and Health Research, Nantes and Tours Universities, 44000 Nantes, France)
- Caroline Victorri-Vigneau
(INSERM UMR 1246, SPHERE, Methods in Patient-Centered Outcomes and Health Research, Nantes and Tours Universities, 44000 Nantes, France
CHU Nantes, Pharmacology Department, Nantes University Hospital, 44000 Nantes, France)
- Marie Grall-Bronnec
(INSERM UMR 1246, SPHERE, Methods in Patient-Centered Outcomes and Health Research, Nantes and Tours Universities, 44000 Nantes, France
HUGOPSY Network, 35000 Rennes, France
CHU Nantes, Addictology and Psychiatry Department, Nantes University Hospital, 44000 Nantes, France)
Abstract
(1) Background: Opioid use disorder (OUD) is a complex condition that can require long-term treatment. Pharmacological therapy for OUD involves treatment with opioid agonists (OMT) tailored to individual profiles. The aim of our study in daily clinical practice was to compare the profiles of patients treated with methadone (MTD) and those using buprenorphine (BHD or BHD-naloxone-NX). (2) Methods: A cross-sectional multicentre study explored the psychological, somatic and social profiles of patients with Opioid Use Disorder (OUD) following Opioid Maintenance Treatment (BHD, BHD/NX, or MTD). Descriptive and comparative analyses were performed (3) Results: 257 patients were included, a majority were men using heroin. 68% (178) were on MTD, 32% (79) were on BHD. Patients with MTD were significantly more likely to report socio-affective damage, and more likely to be younger and not to report oral or sublingual use as the main route for heroin or non-medical opioids (4) Conclusions: In daily clinical practice, regarding OUD damage, only socio-affective damage was significantly more prevalent among patients on MTD than among those on BHD in the multivariate model. Age and route of administration also differed, and our results could raise the issue of the type of OMT prescribed in case of non-medical use of prescribed opioids. These hypothesis should be confirmed in larger studies.
Suggested Citation
Morgane Guillou-Landreat & Antoine Dany & Gaëlle Challet-Bouju & Edouard Laforgue & Juliette Leboucher & Jean Benoit Hardouin & Caroline Victorri-Vigneau & Marie Grall-Bronnec, 2021.
"What Differs between Patients under Methadone and under Buprenorphine for Opioid Use Disorder (OUD) in Daily Clinical Practice in France? A Short Report,"
IJERPH, MDPI, vol. 18(4), pages 1-7, February.
Handle:
RePEc:gam:jijerp:v:18:y:2021:i:4:p:1425-:d:492735
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:18:y:2021:i:4:p:1425-:d:492735. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.